Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
The LOTUSS Trial: An Open-Label, Randomized, Phase 2 Study of the Safety and Tolerability of Pirfenidone When Administered to Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Status: Enrolling
Updated:  8/25/2015
University of Utah
703
mi
from 98109
Salt Lake City, UT
Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
The LOTUSS Trial: An Open-Label, Randomized, Phase 2 Study of the Safety and Tolerability of Pirfenidone When Administered to Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Status: Enrolling
Updated: 8/25/2015
University of Utah
703
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
The LOTUSS Trial: An Open-Label, Randomized, Phase 2 Study of the Safety and Tolerability of Pirfenidone When Administered to Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Status: Enrolling
Updated:  8/25/2015
University of California at San Francisco
682
mi
from 98109
San Francisco, CA
Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
The LOTUSS Trial: An Open-Label, Randomized, Phase 2 Study of the Safety and Tolerability of Pirfenidone When Administered to Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Status: Enrolling
Updated: 8/25/2015
University of California at San Francisco
682
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
The LOTUSS Trial: An Open-Label, Randomized, Phase 2 Study of the Safety and Tolerability of Pirfenidone When Administered to Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Status: Enrolling
Updated:  8/25/2015
The University of Texas, Houston
1892
mi
from 98109
Houston, TX
Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
The LOTUSS Trial: An Open-Label, Randomized, Phase 2 Study of the Safety and Tolerability of Pirfenidone When Administered to Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Status: Enrolling
Updated: 8/25/2015
The University of Texas, Houston
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
The LOTUSS Trial: An Open-Label, Randomized, Phase 2 Study of the Safety and Tolerability of Pirfenidone When Administered to Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Status: Enrolling
Updated:  8/25/2015
St. Joseph's Healthcare
2054
mi
from 98109
Hamilton,
Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
The LOTUSS Trial: An Open-Label, Randomized, Phase 2 Study of the Safety and Tolerability of Pirfenidone When Administered to Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Status: Enrolling
Updated: 8/25/2015
St. Joseph's Healthcare
2054
mi
from 98109
Hamilton,
Click here to add this to my saved trials
Cognitive-behavior Therapy for MS-Related Chronic Pain
Cognitive-behavior Therapy for MS-Related Chronic Pain
Status: Enrolling
Updated:  8/25/2015
VA Connecticut Health Care System
2432
mi
from 98109
West Haven, CT
Cognitive-behavior Therapy for MS-Related Chronic Pain
Cognitive-behavior Therapy for MS-Related Chronic Pain
Status: Enrolling
Updated: 8/25/2015
VA Connecticut Health Care System
2432
mi
from 98109
West Haven, CT
Click here to add this to my saved trials
Cognitive-behavior Therapy for MS-Related Chronic Pain
Cognitive-behavior Therapy for MS-Related Chronic Pain
Status: Enrolling
Updated:  8/25/2015
VA Medical Center, Jamaica Plain Campus
2485
mi
from 98109
Boston, MA
Cognitive-behavior Therapy for MS-Related Chronic Pain
Cognitive-behavior Therapy for MS-Related Chronic Pain
Status: Enrolling
Updated: 8/25/2015
VA Medical Center, Jamaica Plain Campus
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Families Affected by Dementia: A Survey of Caregivers
Religion and Free Will Perceptions as Coping Mechanisms in Caregivers of Individuals With Dementia
Status: Enrolling
Updated:  8/26/2015
University of Miami
2730
mi
from 98109
Coral Gables, FL
Families Affected by Dementia: A Survey of Caregivers
Religion and Free Will Perceptions as Coping Mechanisms in Caregivers of Individuals With Dementia
Status: Enrolling
Updated: 8/26/2015
University of Miami
2730
mi
from 98109
Coral Gables, FL
Click here to add this to my saved trials
Study for Treatment of Cancer in Children With Ataxia-telangiectasia
Pilot Study I for Treatment of Cancer in Children With Ataxia-Telangiectasia
Status: Enrolling
Updated:  8/26/2015
St. Jude Children's Research Hospital
1864
mi
from 98109
Memphis, TN
Study for Treatment of Cancer in Children With Ataxia-telangiectasia
Pilot Study I for Treatment of Cancer in Children With Ataxia-Telangiectasia
Status: Enrolling
Updated: 8/26/2015
St. Jude Children's Research Hospital
1864
mi
from 98109
Memphis, TN
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840041
1116
mi
from 98109
Phoenix, AZ
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840041
1116
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840209
1223
mi
from 98109
Tucson, AZ
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840209
1223
mi
from 98109
Tucson, AZ
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840033
975
mi
from 98109
Loma Linda, CA
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840033
975
mi
from 98109
Loma Linda, CA
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840034
692
mi
from 98109
Modesto, CA
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840034
692
mi
from 98109
Modesto, CA
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840090
989
mi
from 98109
Fort Collins, CO
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840090
989
mi
from 98109
Fort Collins, CO
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840011
2422
mi
from 98109
Fairfield, CT
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840011
2422
mi
from 98109
Fairfield, CT
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840013
2543
mi
from 98109
Maitland, FL
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840013
2543
mi
from 98109
Maitland, FL
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840230
2485
mi
from 98109
Ocala, FL
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840230
2485
mi
from 98109
Ocala, FL
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840022
2527
mi
from 98109
Ormond Beach, FL
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840022
2527
mi
from 98109
Ormond Beach, FL
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840025
2554
mi
from 98109
Sarasota, FL
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840025
2554
mi
from 98109
Sarasota, FL
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840082
2527
mi
from 98109
St. Petersburg, FL
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840082
2527
mi
from 98109
St. Petersburg, FL
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840033
2709
mi
from 98109
Sunrise, FL
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840033
2709
mi
from 98109
Sunrise, FL
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840063
1713
mi
from 98109
Elk Grove Village, IL
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840063
1713
mi
from 98109
Elk Grove Village, IL
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840064
1740
mi
from 98109
Flossmoor, IL
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840064
1740
mi
from 98109
Flossmoor, IL
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840039
1869
mi
from 98109
Ft Wayne, IN
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840039
1869
mi
from 98109
Ft Wayne, IN
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840012
1868
mi
from 98109
Indianapolis, IN
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840012
1868
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840016
1463
mi
from 98109
Des Moines, IA
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840016
1463
mi
from 98109
Des Moines, IA
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840069
mi
from 98109
Clinton Township, MI
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840069
mi
from 98109
Clinton Township, MI
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840253
1793
mi
from 98109
Grand Rapids, MI
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840253
1793
mi
from 98109
Grand Rapids, MI
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840061
1750
mi
from 98109
Traverse City, MI
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840061
1750
mi
from 98109
Traverse City, MI
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840076
1391
mi
from 98109
Minneapolis, MN
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840076
1391
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840079
1962
mi
from 98109
Tupelo, MS
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840079
1962
mi
from 98109
Tupelo, MS
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840310
1718
mi
from 98109
St. Louis, MO
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840310
1718
mi
from 98109
St. Louis, MO
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840060
2233
mi
from 98109
Syracuse, NY
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840060
2233
mi
from 98109
Syracuse, NY
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840029
2282
mi
from 98109
Charlotte, NC
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840029
2282
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840074
1009
mi
from 98109
Bismarck, ND
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840074
1009
mi
from 98109
Bismarck, ND
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840005
1963
mi
from 98109
Cincinnati, OH
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840005
1963
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840078
1961
mi
from 98109
Dayton, OH
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840078
1961
mi
from 98109
Dayton, OH
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840133
1558
mi
from 98109
Tulsa, OK
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840133
1558
mi
from 98109
Tulsa, OK
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840257
146
mi
from 98109
Portland, OR
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840257
146
mi
from 98109
Portland, OR
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840004
2373
mi
from 98109
Philadelphia, PA
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840004
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840068
2226
mi
from 98109
Greenville, SC
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840068
2226
mi
from 98109
Greenville, SC
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840071
1877
mi
from 98109
Cordova, TN
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840071
1877
mi
from 98109
Cordova, TN
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840001
1970
mi
from 98109
Nashville, TN
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840001
1970
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840186
1787
mi
from 98109
San Antonio, TX
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840186
1787
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840006
2372
mi
from 98109
Bennington, VT
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840006
2372
mi
from 98109
Bennington, VT
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840123
2
mi
from 98109
Seattle, WA
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840123
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840020
2126
mi
from 98109
Charleston, WV
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840020
2126
mi
from 98109
Charleston, WV
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 036005
8342
mi
from 98109
Bedford Park,
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 036005
8342
mi
from 98109
Bedford Park,
Click here to add this to my saved trials
Perceptions Regarding Investigational Screening for Memory Problems in Primary Care
Perceptions Regarding Investigational Screening for Memory Problems in Primary Care: The PRISM-PC Study
Status: Enrolling
Updated:  8/27/2015
Indiana University Medical Group
1867
mi
from 98109
Indianapolis, IN
Perceptions Regarding Investigational Screening for Memory Problems in Primary Care
Perceptions Regarding Investigational Screening for Memory Problems in Primary Care: The PRISM-PC Study
Status: Enrolling
Updated: 8/27/2015
Indiana University Medical Group
1867
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Indiana University
1866
mi
from 98109
Indianapolis, IN
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Indiana University
1866
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Columbia University Medical Center / Center for Liver Disease and Transplantation
2400
mi
from 98109
New York, NY
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Columbia University Medical Center / Center for Liver Disease and Transplantation
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials